Extended Dual Versus Single Anti‐Platelet Therapy Following Percutaneous Coronary Intervention: A Bayesian Meta‐Analysis and Regression on All‐Cause Mortality

Abstract

Extended DAPT is associated with a higher all-cause mortality, bleeding events, and NACE. While DAPT may benefit high-risk populations, the increased odds of adverse events are significantly associated with mortality, warranting that it be carefully considered and monitored in post-PCI patients.